Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Eastman Chemical in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Eastman Chemical’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:58 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000915389-26-000099
| (Dollars in millions, except per share amounts) | First Quarter / 2026 | First Quarter / 2025 |
|---|---|---|
| Cost of sales | 1,746 | 1,723 |
| Gross profit | 431 | 567 |
| Selling, general and administrative expenses | 178 | 182 |
| Research and development expenses | 60 | 67 |
| Asset impairments, restructuring, and other charges, net | 9 | 9 |
| Other components of post-employment (benefit) cost, net | (17) | (1) |
| Other (income) charges, net | 13 | 8 |
| Earnings before interest and taxes | 188 | 302 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Eastman Chemical's R&D?
- Eastman Chemical (EMN) reported R&D of $60M in Q1 2026.
- How has Eastman Chemical's R&D changed year-over-year?
- Eastman Chemical's R&D decreased by 10.4% year-over-year, from $67M to $60M.
- What is the long-term trend for Eastman Chemical's R&D?
- Over 4 years (2021 to 2025), Eastman Chemical's R&D has grown at a 0.1% compound annual growth rate (CAGR), from $254M to $255M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Eastman Chemical's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude